Cargando…

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study

OBJECTIVES: The aim was to use routine data available at a patient’s admission to the hospital to predict polypharmacy and drug–drug interactions (DDI) and to evaluate the prediction performance with regard to its usefulness to support the efficient management of benefits and risks of drug prescript...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolff, Jan, Hefner, Gudrun, Normann, Claus, Kaier, Klaus, Binder, Harald, Domschke, Katharina, Hiemke, Christoph, Marschollek, Michael, Klimke, Ansgar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043005/ https://www.ncbi.nlm.nih.gov/pubmed/33837103 http://dx.doi.org/10.1136/bmjopen-2020-045276

Ejemplares similares

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders
por: Wolff, Jan, et al.
Publicado: (2021)

Predicting the risk of drug-drug interactions in psychiatric hospitals
por: Wolff, J., et al.
Publicado: (2021)

Predicting patient outcomes in psychiatric hospitals with routine data: a machine learning approach
por: Wolff, J., et al.
Publicado: (2020)

Hospital costs associated with psychiatric comorbidities: a retrospective study
por: Wolff, Jan, et al.
Publicado: (2018)

Forecasting admissions in psychiatric hospitals before and during Covid-19: a retrospective study with routine data
por: Wolff, J., et al.
Publicado: (2022)

A prospective study of adverse drug reactions to antiepileptic drugs in children
por: Anderson, Mark, et al.
Publicado: (2015)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
por: Noguchi, Yoshihiro, et al.
Publicado: (2023)

Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden
por: Loikas, Desirée, et al.
Publicado: (2013)

A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study
por: Schjøtt, Jan, et al.
Publicado: (2012)

Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study
por: Huang, Jing, et al.
Publicado: (2023)

Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
por: Sharma, Megha, et al.
Publicado: (2021)

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems
por: Kaufmann, Carole P, et al.
Publicado: (2018)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001–2012
por: Ward, Derek J, et al.
Publicado: (2014)

Antidopaminergic drugs and acute pancreatitis: a population-based study
por: Bodén, Robert, et al.
Publicado: (2012)

Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway
por: Westin, Andreas Austgulen, et al.
Publicado: (2017)

Assessment of drug use pattern using WHO core drug use indicators in selected general hospitals: a cross-sectional study in Tigray region, Ethiopia
por: Tassew, Segen Gebremeskel, et al.
Publicado: (2021)

Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)
por: Kravchenko, Olga V, et al.
Publicado: (2022)

Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
por: Minjon, Lenneke, et al.
Publicado: (2022)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
por: Létinier, Louis, et al.
Publicado: (2021)

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
por: Kaufmann, Carole P, et al.
Publicado: (2015)

Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review
por: Lunghi, Carlotta, et al.
Publicado: (2022)

Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions
por: Fleet, Jamie L, et al.
Publicado: (2013)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

How are drug regimen changes during hospitalisation handled after discharge: a cohort study
por: Viktil, Kirsten K, et al.
Publicado: (2012)

Health Canada's use of its priority review process for new drugs: a cohort study
por: Lexchin, Joel
Publicado: (2015)

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions
por: Osanlou, Rostam, et al.
Publicado: (2022)

Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review
por: Moe-Byrne, Thirimon, et al.
Publicado: (2014)

Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981–2014: a retrospective observational study
por: Ward, Derek J, et al.
Publicado: (2015)

Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study
por: Gidey, Kidu, et al.
Publicado: (2020)

Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain
por: Lestón Vázquez, Marta, et al.
Publicado: (2023)

Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study
por: Sadowski, Alexander, et al.
Publicado: (2013)

Evaluation of exposure to effervescent drugs in a large health check-up population in France: a cross-sectional study
por: Perrin, Germain, et al.
Publicado: (2018)

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study
por: Zeitoun, Jean-David, et al.
Publicado: (2017)

Trends of prescribing antimicrobial drugs for urinary tract infections in primary care in the Netherlands: a population-based cohort study
por: Mulder, Marlies, et al.
Publicado: (2019)

Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia
por: Sendekie, Ashenafi Kibret, et al.
Publicado: (2023)

Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA
por: Hiayev, Stephany, et al.
Publicado: (2023)

The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey
por: Sjölander, Maria, et al.
Publicado: (2013)

Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients
por: Kiguba, Ronald, et al.
Publicado: (2017)

Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs
por: Giannuzzi, Viviana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uoje53gh4qdo7brfqkhprkmtng